Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 10 AND SODIUM CHLORIDE 0 45 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 10 AND SODIUM CHLORIDE 0 45 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of carbohydrates to increase blood glucose concentrations, while sodium chloride acts as a source of electrolytes to maintain osmotic pressure and fluid balance.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion. Dose is individualized based on fluid, electrolyte, and caloric needs. Typical adult maintenance: 100-200 mL/hour of D10 0.45% NaCl, providing 10-20 g/hour dextrose and 77-154 mEq/L sodium. Maximum infusion rate: 0.5-0.8 g/kg/hour dextrose.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateFor exogenous glucose, the terminal elimination half-life is approximately 2-4 hours in healthy individuals, but may be prolonged in renal impairment or diabetes due to altered insulin dynamics. Sodium and chloride have no defined half-life as electrolytes; their renal clearance maintains homeostasis.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose is metabolized to carbon dioxide and water; excretion of unchanged glucose in urine is minimal (<0.5%) in euglycemic patients. Sodium and chloride are primarily excreted renally (90-95%) with minor fecal loss (<5%).
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."